Lupus de inicio tardío. Presentación de caso
Keywords:
Lupus Eritematoso SistémicoAbstract
El lupus eritematoso sistémico es una enfermedad autoinmune, sistémica, caracterizada por la producción de autoanticuerpos y una diversidad de manifestaciones clínicas. Algunas evidencias sugieren que los pacientes que sufren esta enfermedad pueden ser divididos en subgrupos más homogéneos; la raza, el sexo, la edad al diagnóstico y el perfil de autoanticuerpos son factores modificadores de su curso y pronóstico; cuando se le asocian además manifestaciones clínicas particulares, pueden determinar subgrupos especiales de esta entidad. Se presenta una paciente de 62 años de edad con un síndrome febril prolongado, asociado a un síndrome general expresado por pérdida de peso, astenia y anorexia, que ingresa en el Centro Nacional de Reumatología el 24 de enero del 2010, para estudio de enfermedad inflamatoria del tejido conectivo, diagnosticándose al egreso como un Lupus Eritematoso Sistémico de inicio tardío.
Downloads
References
Alarcón Segovia D. Tratado hispanoamericano de Reumatología, volumen II, Editorial Nomos S.A. Bogotá, 2006: 755.
Michet CJ, McKenna CH, Elveback LR et al. Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979. Mayo Clin Proc. 1985;60:105-13.
Jonsson H, Nived O, Sturfelt G, Silman A. Estimating the incidence of systemic lupus erythematosus in a defined population using multiple sources of retrieval. Br J Rheumatol. 1990; 29:185-8.
Boddaert J, Huong D, Amoura Z, Wechsler B, Godeau P, Piette JC. Late-onset systemic lupus erythematosus: a personal series of 47 patients and pooled analysis of 714 cases in the literatura. Medicine. 2004; 83: 348-59.
Cooper GS, Dooley MA, Treadwell EL et al. Risk factors for development of systemic lupus erythematosus: allergies, infections, and family history. J Clin Epidemiol. 2002; 55: 982-9.
Romero-Díaz J, Martín-Domenech R, Sánchez-Guerrero J. Differences in damage accrual between male and female patients with systemic lupus erythematosus. Arthritis Rheum. 2002; 46: 264.
Molina JF, Drenkard C, Molina J et al. Systemic lupus erythematosus in males. A study of 107 Latin American patients. Medicine. 1996; 75: 124-30.
Guibert Toledano M, Reyes Llerena G, Hernández Martínez A, Torres Carballeira R. Medición de actividad Lúpica en pacientes portadores de Lupus Eritematoso Sistémico. Rev. Cubana de Reumatol. 2000; II (1): 4- 11.
Estévez del Toro Miguel, Chico Capote Araceli, Jiménez Paneque Rosa, Marin Gil José Miguel, Castell Pérez Concepción, Kokuina Elena. Supervivencia en pacientes cubanos con lupus eritematoso sistémico, influencia de las características iniciales de la enfermedad. Rev cubana med. 2008; 47(3).
Guibert Toledano M, Reyes Llerena G, López Cabreja G, González Otero Z, Betancourt Herrera L. Índice de daño en el Lupus Eritematoso Sistémico (slicc/acr). Su análisis en pacientes cubanos; 1997-1998. Rev. Cubana de Reumatol. 2000; II (1): 45- 8.
Estévez del Toro Miguel, Chico Capote Araceli, Hechavarría Rafael, Jiménez Paneque Rosa, Kokuina Elena. Daño en pacientes cubanos con lupus eritematoso sistémico. Relación con características de la enfermedad. Reumatol Clin. 2010; 06: 11- 5.
Guibert Toledano M, Reyes Llerena G, Hernández Martínez A, López Cabreja G, Torres Moya R. Lupus Neuropsiquiátrico. Resultados y experiencias de diez años de trabajo en Servicio Nacional de Reumatología. Rev. Cubana de Reumatol. 1999; I (1): 10- 14.
Guibert Toledano M, Reyes Llerena G, López Aguilera IR, López Mantecón AM, García Estiven A, Izquierdo González M, Junco V. Mecanismos patogénicos, actividad y daño en la enfermedad renal por lupus eritematoso sistémico. Rev. Cubana de Reumatol. 2006; VIII (9 y 10): 52- 64.
Estévez del Toro Miguel, Chico Capote Araceli, Sánchez Bruzón Yeniset, Gutiérrez Rojas Ángela, Chong López Agustín. Factores predictores de la respuesta a la terapia de inducción con ciclofosfamida en nefritis lúpica proliferativa. Rev cubana med. 2007; 46 (2).
Catoggio L, Skinner RP, Smith G, Maddison PJ. Systemic lupus erythematosus in the elderly: clinical and serological characteristics. J Rheumatol. 1984; 11: 175-81.
Tan EM, Cohen AS, Fries J. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25:1271-7.
Baker SB, Rovira JR, Campion EW, Mills JA. Late onset systemic lupus erythematosus. Am J Med. 1979; 66: 727- 32.
Bertoli AM, Alarcón GS, Calvo-Alén J, Fernández M, Vilá LM, Reveille JD. Systemic lupus erythematosus in a multiethnic US cohort. Arthritis Rheum. 2006; 54: 1580- 87.
Ho C, Mok C, Lau C, Wong R. Late onset systemic lupus erythematosus in southern Chinese. Ann Rheum Dis. 1998; 57: 437- 40.
Padovan M, Govoni M, Castellano G, Rizzo N, Fontinidi M, Trotta F. Late onset systemic lupus erythematosus: no substancial differences using different cut-off ages. Rheumatol Int. 2007; 27: 735- 41.
Gaviria LM, Rodelo JR, Uribe O, Vásquez G, Ramírez LA. Características clínicas y serológicas de los pacientes con LES de inicio tardío en una población colombiana. Rev Colombiana de Reumatol. 2007; 14: 23-31.
González Naranjo LA, Ramírez Gómez LA. Lupus eritematoso sistémico de inicio tardío. Rev Colombiana de Reumatol. 2008; 15(3): 24- 32.
Foad BS, Sheon RP, Kirsner AB. Systemic lupus erythematosus in the elderly. Arch Intern Med. 1972; 130: 743- 46.
Koh ET, Boey ML. Late onset lupus: a clinical and immunological study in a predominantly Chinese population. J Rheumatol 1994; 21: 1463- 67.
Formiga F, Moga I, Pac M, Mitjavila F, Rivera A, Pujol R. Mild presentation of systemic lupus erythematosus in elderly patients assessed by SLEDAI. Lupus. 1999; 8: 462- 65.
Voulgari PV, Katsimbri P, Alamanos Y, Drosos AA. Gender and age differences in systemic lupus erythematosus. A study of 489 Greek patients with a review of the literature. Lupus. 2002; 11: 722- 29.
Ballou SP, Khan MA, Kushner I. Clinical features of systemic lupus erythematosus. Arthritis Rheum. 1982; 25: 55- 60.
Ward MM, Polisson RP. A meta-analysis of the clinical manifestations of older-onset systemic lupus erythematosus. Arthritis Rheum. 1989; 32: 1226- 32.
Pu SJ, Luo SF, Wu YIJ, Cheng HS, Ho HH. The clinical features and prognosis of lupus with disease onset at age 65 and older. Lupus. 2000; 9: 96-100.
Gaviria LM, Rodelo J, Ramírez LA. Late onset systemic lupus erythematosus: clinical, immunological and serological features between subgroups. Ann Rheum Dis. 2008; 67 (suppl II): 485.
Domenech I, Aydintug R, Cervera R, Khamashta M, Jedryka-Goral A, Vianna JL, Hughes GR. Systemic lupus erythematosus in 50 year olds. Postgrad Med J. 1992; 68: 440- 44.
Hochberg MC, Florsheim F, Scott J et al. Familial aggregation of systemic lupus erythematosus. Am J Epidemiol. 1985; 122: 526-31.
Lawrence JS, Martins L, Drake G. A family survey of lupus erythematosus: I. Heritability. J Rheumatol. 1987; 14: 913- 21.
Guibert Toledano M, López Mantecón AM, Reyes Llerena G, Hernández Martínez A, Molinero Rodríguez C, Sotolongo García Y, Valladares Oliva. C. Realidad, Incertidumbre y Reflexiones: Lupus Neuropsiquiátrico; presentación y discusión de 3 casos. Rev. Cubana de Reumatol. 2002; IV (2): 22- 9
Hochberg MC. The incidence of systemic lupus erythematosus in Baltimore, Maryland, 1970-1977. Arthritis Rheum. 1985; 28: 80- 6.
Maddison PJ. Systemic lupus erythematosus in the elderly. J Rheumatol. 1987; 14: 182- 87.
Cervera R, Khamashta MA, Font J, Sebastiani GD, Gil A, Lavilla P, Doménech I, Aydintug AO, Jedryka-Góral A, de Ramón E, et al. Systemic lupus erythematosus: clinical and immunologic patterns of disease expression in a cohort of 1,000 patients. The European Working Party on Systemic Lupus Erythematosus. Medicine. 1993; 72: 113- 24.
Font J, Pallarés L, Cervera R, López-Soto A, Navarro M, Bosch X, Ingelmo M. Systemic lupus erythematosus in the elderly: clinical and immunological characteristics. Ann Rheum Dis. 1991; 50: 702- 05.
Published
How to Cite
Issue
Section
License
Warning of rights of author
The authors that publish in this journal agree with the following terms:
The authors conserve the rights of author and concede to the journal the right of the first publication, fulfilling with the license Creative Commons Attribution License that allows to others share the work with recognition of the authorship of their articles, and the initial publication in this journal.
The authors can establish separately additional agreements for the no exclusive distribution of the version of the work published in the journal (for example, situate it in an institutional repository, in a personal blog or publish it partial or totally in a book), with a recognition of their initial publication in this journal.
To be able to send the manuscript or part of him passed three months of published, for his evaluation to other publishers, identifying it or not with the same title; whenever allusion is made to our journale and know it the new publisher.
The publishing committee of the Cuban Journal of Rheumatology authorizes to other publishers, to reproduce the articles published in our magazine, whenever it indicate the origin of the same.
The authors should send a document in Office Word application format through the electronic address of the magazine with a similar format to that we include next:
---------------------------------------------------------------------------------------------------------------------
Statement of authorship and cede of articles for the publication of the scientific work in the Cuban Journal of Rheumatology
Date:
Those who subscribe certify that are the authors of the work:
Of this form communicate the originality of our article clearing that the concepts and knowledges of other authors that have included in the text of the article, have been quoted properly in the bibliography.
We do proof besides that the article in question is original and has not been published, total neither partially, in another journal.
To be approved for his publication in the Cuban Journal of Rheumatology, do secession of the rights of publication to the same one through the method that realizes it usually.
In front of any catchword that exist by the article that send to evaluate, relieve of of the responsibility to the Cuban Journal of Rheumatology holding us responsible with all the difficulties that can berelated by any situation.
We include to continuation the name and the signature of all authors and collaborators of this article.
Name: Signature:
